About IQGEN-X Pharma
IQGEN-X Pharma is a Healthcare company based in Mumbai (India) founded in 2016. Solid and liquid pharmaceutical formulations are manufactured and developed. IQGEN-X Pharma has raised $1.35 million across 1 funding round from investors including ACG Group. The company has 34 employees. IQGEN-X Pharma was last valued at $4.2 million in October 2020. Its Indian entity Iqgen-X Pharma Private Limited reported revenue of ₹8.51 Cr. IQGEN-X Pharma offers products and services including Formulation Development and ANDA Filing. Its focus areas include Biopharma Outsourcing, CRO and Drug Discovery.
Company details
IQGEN-X Pharma was established in 2016 in Mumbai, India, within the pharmaceutical sector. Finished formulations, including solid and sterile liquids, are developed and produced for multiple therapeutic categories. Solid options encompass quick-release, conventional-release, extended-release tablets, oral suspensions, nasal sprays, and dry powder inhalers. Operations focus on these formats to support drug delivery needs.
- Headquarters Mumbai, India
- Employees 34
- Stage Minicorn
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website iqgenx.com
- Social LinkedIn Facebook
- Legal Name Iqgen-X Pharma Private Limited
- Date of Incorporation 13 Oct, 2016
- Jurisdiction Navi Mumbai, Maharashtra, India
- Annual Revenue₹8.51 Cr
FY 2023 · -14% YoY
- Net Loss-₹25.9 Lakh
FY 2023 · -3% margin
- EBITDA₹1.16 Cr
FY 2023 · 14% margin
- Total Equity Funding$1.35M (USD)
in 1 rounds
- Latest Funding Round$1.35M (USD), Seed
Oct 2020
- Investors
- Employee Count34
Associated legal entities of IQGEN-X Pharma
IQGEN-X Pharma operates through Iqgen-X Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Iqgen-X Pharma Private Limited CIN U74999MH2016PTC286716 | Active | 13 Oct 2016 | Navi Mumbai, Maharashtra | ₹8.5 Cr | 34 | 5 | View details |
Products & Services of IQGEN-X Pharma
IQGEN-X Pharma offers a comprehensive portfolio of products and services, including Formulation Development and ANDA Filing.
Service for developing pharmaceutical formulations and scale-up.
Assistance in filing Abbreviated New Drug Applications for generics.
Funding Insights of IQGEN-X Pharma
IQGEN-X Pharma has successfully raised a total of $1.35M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.35 million completed in October 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.35M
- Total Rounds 1
- Last Round Seed — $1.35M
- First Round $1.35M
(Oct 2020)
- Investors Count 1
All 1 funding rounds of IQGEN-X Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2020 | $1.35M | Seed | $4.2M | ACG Group | – |
| Date | Valuation | Stage |
|---|---|---|
| Oct 2020 | $4.2M | •••••••• |
Last known valuation $4.2M (Oct 2020). 1 investors in total: 1 institutional.
Investors in IQGEN-X Pharma
IQGEN-X Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include ACG Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Manufacturer & supplier of solid dosage products, pharmaceutical machinery and equipment, and packaging solutions | 1961 | acg-world.com | Mumbai, India |
Investor details for IQGEN-X Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Iqgen-X Pharma Private Limited (IQGEN-X Pharma)
Iqgen-X Pharma Private Limited is the primary company behind IQGEN-X Pharma. The board of Iqgen-X Pharma Private Limited currently have 5 directors; the longest-serving is Madhu Hariharan, appointed in 2017. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Madhu Hariharan DIN 06384549 | Director | 01 Apr 2017 | 9 yrs 6 mo | Iqgen-X Pharma Private Limited |
| Mandar Madhukar Kodgule DIN 07734636 | Director | 01 Apr 2017 | 9 yrs 6 mo | Iqgen-X Pharma Private Limited |
| Yogita Mandar Kodgule DIN 07812969 | Director | 01 Apr 2017 | 9 yrs 6 mo | Iqgen-X Pharma Private Limited |
| Yatendra Kumar DIN 07698827 | Director | 01 Apr 2017 | 9 yrs 6 mo | Iqgen-X Pharma Private Limited |
| Parizad Adil Elchidana DIN 00394075 | Additional Director | 30 Sep 2021 | 5 yrs | Iqgen-X Pharma Private Limited |
Financials of IQGEN-X Pharma
Figures of Iqgen-X Pharma Private Limited, the primary company behind IQGEN-X Pharma, for FY 2023. Revenue was ₹8.51 Cr (-14% year on year). Net loss was -₹25.9 Lakh (-3% margin). EBITDA was ₹1.16 Cr (14% margin). Revenue has grown at a compounded annual rate of +4% over three years and +23% over five years.
- ₹8.51 CrRevenue · FY 2023 · -14% YoY
- -₹25.9 LakhNet loss · -3% margin
- ₹1.16 CrEBITDA · 14% margin
- ₹1.13 CrPaid-up capital
- 34Employees (provident fund records)
- +4%Revenue CAGR, 3 years
- +23%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Iqgen-X Pharma Private Limited are on its company page.
Detailed financial statements for IQGEN-X Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of IQGEN-X Pharma
3 dated milestones of IQGEN-X Pharma across 4 years, from founding to its latest funding, stage changes and deals.
- Founded IQGEN-X Pharma is founded.
- Funding First funding round of $1.4M.
- Milestone Reaches Minicorn status.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as IQGEN-X Pharma (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Iqgen-X Pharma
Complete news archive for IQGEN-X Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about IQGEN-X Pharma
IQGEN-X Pharma was founded in 2016 and raised its 1st funding round 4 years after it was founded.
IQGEN-X Pharma is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
IQGEN-X Pharma is a funded company, having raised a total of $1.35M across 1 funding round to date. The company's 1st funding round was a Seed of $1.35M, raised on Oct 2020.
IQGEN-X Pharma has 34 employees.
The primary company behind IQGEN-X Pharma, Iqgen-X Pharma Private Limited, reported revenue of ₹8.51 Cr for FY 2023, down 14% year on year.
IQGEN-X Pharma was established in 2016 in Mumbai, India, within the pharmaceutical sector. Finished formulations, including solid and sterile liquids, are developed and produced for multiple therapeutic categories. Solid options encompass quick-release, conventional-release, extended-release tablets, oral suspensions, nasal sprays, and dry powder inhalers. Operations focus on these formats to support drug delivery needs.
IQGEN-X Pharma offers Formulation Development and ANDA Filing.
IQGEN-X Pharma has 1 investor. Key investors include ACG Group.
The valuation of IQGEN-X Pharma is $4.2M as of Oct 2020.
IQGEN-X Pharma operates through Iqgen-X Pharma Private Limited.
The legal entities of IQGEN-X Pharma currently have 5 directors, including Madhu Hariharan, Mandar Madhukar Kodgule, Yogita Mandar Kodgule and others.